Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model

Ferric citrate (FC) has demonstrated efficacy as a phosphate binder and reduces the requirements for erythropoiesis-stimulating agents (ESAs) and intravenous (IV) iron in dialysis patients. We developed a net budgetary impact model to evaluate FC vs. other phosphate binders from the vantage of a lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunelli, Steven M., Sibbel, Scott P., Van Wyck, David, Sharma, Amit, Hsieh, Andrew, Chertow, Glenn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318331/
https://www.ncbi.nlm.nih.gov/pubmed/28078600
http://dx.doi.org/10.1007/s40268-016-0163-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318331/
https://www.ncbi.nlm.nih.gov/pubmed/28078600
http://dx.doi.org/10.1007/s40268-016-0163-7

Ejemplares similares